Law360, Philadelphia (April 24, 2015, 1:15 PM EDT) -- Bayer Corp. and several other pharmaceutical companies were hit with a Pennsylvania state court lawsuit on Thursday in which a Philadelphia man claimed the company's MiraLax laxative was responsible for his acute kidney injury.
Samuel Woniewala said that he suffered the condition known as oxalate nephropathy from his use of the over-the-counter product. As a result, he will require ongoing treatment and dialysis, and he also faces the prospect of a kidney transplant, Woniewala said.
"At all times relevant and material hereto, the defendants manufactured, marketed, sold and advertised MiraLax, without sufficiently investigating the effect of MiraLax on kidney function, and/or...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!